What are the long-term outcomes of ixekizumab therapy in terms of durability of response and maintenance of skin clearance?
Featuring Tina Bhutani, MD, MAS |
CEO, Synergy Dermatology
Associate Clinical Professor of Dermatology
University of California, SF
San Francisco, CA
Related Media
Powered by Polaris TM